Deferataj 125mg Tablet DT

Deferataj 125mg Tablet DT is used for treating chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients two years older. It can also be indicated for treating chronic iron overload in patients ten years of age and older with non-transfusion-dependent thalassemia (NTDT).

The active ingredient in Deferataj 125mg Tablet DT is deferasirox, which binds the excess iron and eliminates it through faeces. The danger of organ damage is reduced as a result.

In some cases, you may experience common side effects such as diarrhoea, vomiting, nausea, abdominal pain, and skin rashes. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Avoid taking Deferataj 125mg Tablet DT if you are allergic to it. Do not use Deferataj 125mg Tablet DT without a doctor's advice if you have a skin reaction or irritation to any medicine. Consult your doctor before using the Deferataj 125mg Tablet DT if you are pregnant or breastfeeding. Do not use Deferataj 125mg Tablet DT in more than prescribed doses or for a longer duration as it may cause adverse effects. Keep your doctor informed about your health condition and all the medicines you take before taking Deferataj 125mg Tablet DT to rule out any side effects.

Deferataj 125mg Tablet DT is used for treating chronic iron overload that occurs due to blood transfusions. The detailed uses of Deferataj 125mg Tablet DT are as follows:

• Transfusional hemosiderosis: Used for treating chronic iron overload that occurs due to blood transfusions in patients two years of age and older.
• Non-transfusion-dependent thalassemia (NTDT): Deferataj 125mg Tablet DT can also be indicated for treating chronic iron overload in patients ten years of age and older with non-transfusion-dependent thalassemia.

• Deferataj 125mg Tablet DT should be taken on an empty stomach, at least 30 minutes before a meal.
• Follow your doctor's instructions on the dosage and timing of this medication. However, it is suggested to take Deferataj 125mg Tablet DT at the same time each day to maintain a consistent level of medicine in your body.
• Swallow the whole Deferataj 125mg Tablet DT with a glass of water.
• Do not break, chew, or crush it.

• Deferasirox is the active component in Deferataj 125mg Tablet DT.
• It's a chelating agent that selectively binds to trivalent iron.
• It binds extra iron and excretes it in the faeces. As a result, the risk of organ damage is lowered.

• Do not take Deferataj 125mg Tablet DT if you are allergic to Deferataj 125mg Tablet DT or its ingredients.
• Deferataj 125mg Tablet DT is not usually recommended if you are a pregnant or lactating woman; there is not enough information to say whether it's safe.
• It is unknown whether Deferataj 125mg Tablet DT alters the ability to drive, so do not drive or operate machinery if you experience any symptoms affecting your ability to concentrate and react.
• Seek medical attention if the symptoms persist longer.
• Avoid consuming alcohol along with Deferataj 125mg Tablet DT as it could lead to unpleasant side effects.
• Should monitor elderly and paediatric patients closely for toxicity.